Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Optimizing Downstream Processing for an Inactivated Rabies Vaccine

MilliporeSigma:

Youness Cherradi, PhD, Senior Process Development Scientist, EMEA, Bioprocessing
Youssef Gaabouri, Associate Director Sales, North & West Africa, Bioprocessing
Anissa Boumlic, PhD, Head of Global Vaccine & Plasma Segments, Bioprocessing

Institut Pasteur de Tunis:

Héla Kallel, PhD, Head of the Biotechnology Development Group
Khaled Trabelsi, PhD, Senior Engineer, interim Head of the Biotechnology Development Group

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Login

Subscribe to The Medicine Maker Newsletters

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register